|
BioPharm America 2017, Sep. 26-27, Boston, MA
|
5
|
Resverlogix Corp.
|
Sep 16, 2017 11:36AM
|
|
Re: Stonegate Capital Partners Research Report 3/19/2018
|
5
|
Resverlogix Corp.
|
Mar 19, 2018 06:39PM
|
|
Re: New ATB blog posting:
|
5
|
Resverlogix Corp.
|
Aug 16, 2016 03:35AM
|
|
Re: Bear
|
5
|
Resverlogix Corp.
|
Jan 30, 2020 03:20PM
|
|
Re: Transcript RVX_191031_AGM
|
5
|
Resverlogix Corp.
|
Nov 01, 2019 09:36AM
|
|
Re: If BP buys Apabetalone,...
|
5
|
Resverlogix Corp.
|
Nov 07, 2019 05:09PM
|
|
Re: Heart Failure
|
5
|
Resverlogix Corp.
|
Apr 07, 2020 09:08AM
|
|
Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
|
5
|
Resverlogix Corp.
|
Jun 09, 2020 08:49PM
|
|
Slides up for "LDL-C: DONE DEAL, NEXT EPIGENETICS?" Symposium
|
5
|
Resverlogix Corp.
|
Oct 10, 2018 10:15AM
|
|
Re: Secondary indications
|
5
|
Resverlogix Corp.
|
Jan 24, 2019 12:43PM
|
|
Re: Goodbye March, Hello April
|
5
|
Resverlogix Corp.
|
Mar 26, 2019 11:32AM
|
|
Re: The CKD opportunity
|
5
|
Resverlogix Corp.
|
Jul 27, 2017 10:38AM
|
|
Re: 3 point MACE vs 5 point MACE
|
5
|
Resverlogix Corp.
|
Nov 02, 2018 11:48PM
|
|
Re: Clinical trials query results
|
5
|
Zenith Epigenetics
|
Apr 08, 2021 01:10PM
|
|
Re: DSMB 7th review??
|
5
|
Resverlogix Corp.
|
Jul 18, 2018 11:11AM
|
|
Re: so what happens if dm fumbles the ball??
|
5
|
Resverlogix Corp.
|
Jul 12, 2020 08:52AM
|
|
Re: Diving into....
|
5
|
Resverlogix Corp.
|
Sep 28, 2019 01:07PM
|
|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
5
|
Resverlogix Corp.
|
Nov 20, 2019 08:54AM
|
|
Re: We don't need another Hub
|
5
|
Resverlogix Corp.
|
Dec 03, 2015 10:49AM
|
|
Re: Waiting for the shoe to drop....
|
5
|
Resverlogix Corp.
|
Apr 19, 2018 05:56PM
|
